REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

REGENXBIO (Nasdaq: RGNX) will participate in two upcoming investor events: the 2026 RBC Capital Markets Global Healthcare Conference fireside chat on May 20, 2026 at 9:30 a.m. ET in New York, and the Stifel 2026 Virtual Ophthalmology Forum fireside chat on May 26, 2026 at 9:30 a.m. ET.

Live webcasts and 30-day replays will be available in the Investors section of REGENXBIO's website.

News Market Reaction – RGNX

+0.18%

3 alerts

+0.18% Session close to close

-4.9% Trough Tracked

$295.25M Market Cap

0.0x Rel. Volume

In the May 19 session, RGNX gained 0.18%, reflecting a mild positive market reaction. Argus tracked a trough of -4.9% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKVILLE, Md., May 18, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:

2026 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 20 at 9:30am ET
Location: New York, NY

Stifel 2026 Virtual Ophthalmology Forum
Fireside Chat: Tuesday, May 26 at 9:30am ET
Location: Virtual

Live webcasts of select events can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. Archived replays of the webcasts will be available for approximately 30 days following the events.

ABOUT REGENXBIO Inc.
REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA®. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.

Contacts:

Dana Cormack
Corporate Communications
dcormack@regenxbio.com

Investors:
George E. MacDougall
Investor Relations
IR@regenxbio.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302775147.html

SOURCE REGENXBIO Inc.

FAQ

When will REGENXBIO (RGNX) present at the 2026 RBC Capital Markets Global Healthcare Conference?

REGENXBIO will join a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on May 20, 2026 at 9:30 a.m. ET. According to REGENXBIO, the event will take place in New York, with a live webcast available via its investor website.

What is the date and time of REGENXBIO's fireside chat at the Stifel 2026 Virtual Ophthalmology Forum?

REGENXBIO is scheduled for a fireside chat at the Stifel 2026 Virtual Ophthalmology Forum on May 26, 2026 at 9:30 a.m. ET. According to REGENXBIO, this event is virtual and can be accessed through the Investors section of its website.

How can investors access the REGENXBIO (RGNX) investor conference webcasts in May 2026?

Investors can access live webcasts of select May 2026 REGENXBIO investor events through the Investors section of the company’s website. According to REGENXBIO, archived replays of these webcasts will remain available online for approximately 30 days after the events.

Will replays of REGENXBIO's May 2026 investor conference fireside chats be available to shareholders?

Yes, replays of REGENXBIO’s May 2026 investor conference fireside chats will be available. According to REGENXBIO, archived webcast replays will be accessible in the Investors section of its website for approximately 30 days following the live events.

Which investor conferences is REGENXBIO (RGNX) joining in May 2026?

REGENXBIO is joining the 2026 RBC Capital Markets Global Healthcare Conference and the Stifel 2026 Virtual Ophthalmology Forum in May 2026. According to REGENXBIO, both appearances feature fireside chats scheduled for 9:30 a.m. ET on May 20 and May 26, respectively.